Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Elkhart
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Elkhart, IN

Studies commonly pay $75 to $4,500 per completed study

105 clinical trials are currently recruiting participants within 30 miles of Elkhart. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

105studies recruiting
8+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Elkhart right now

Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Breast Cancer, TNBC - Triple-Negative Breast Cancer N/A Observational 900 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: Tempus AI

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Failed or Difficult Intubation, Sequela, Intubation; Difficult N/A Observational 150,000 participants sought
Beacon Children's Hospital — South Bend, Indiana (14.8 mi) · Sponsor: Children's Hospital of Philadelphia

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Midwest Cardiovascu Rsrch Foundation — Elkhart, Indiana (1.0 mi) · Sponsor: Novo Nordisk A/S

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Digestive Research Alliance of Michiana — South Bend, Indiana (14.8 mi) · Sponsor: Eli Lilly and Company

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi) · Sponsor: Akero Therapeutics, Inc

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity Phase 2 Interventional 338 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi) · Sponsor: OHB Neonatology Ltd.

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Lakeland Hospital Niles — Niles, Michigan (17.8 mi) · Sponsor: SWOG Cancer Research Network

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi) · Sponsor: National Cancer Institute (NCI)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi) · Sponsor: Boehringer Ingelheim

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: Children's Oncology Group

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: SWOG Cancer Research Network

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — South Bend, Indiana (14.8 mi) · Sponsor: Alnylam Pharmaceuticals

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: NRG Oncology

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 700 participants sought
Indiana University — Goshen, Indiana (10.0 mi) · Sponsor: Janssen Research & Development, LLC

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: Children's Oncology Group

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: NRG Oncology

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi) · Sponsor: 89bio, Inc.

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near Elkhart

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Elkhart

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Indiana Medical Research

303 S Nappanee St, Elkhart, IN 46514
(574) 296-3200

Center for Rare and Neglected Diseases

18885 Moose Krause Cir Galvin Life Sciences Center, Notre Dame, IN 46556
(574) 631-8831

Digestive Research Alliance of Michiana

★ 5.0
53830 Generations Dr Ste 110, South Bend, IN 46635
(574) 393-9755

Velocity Clinical Research

★ 4.5
55 University Dr Ste 106, Valparaiso, IN 46383
(219) 464-8302
"Do go there, 2 minutes to load a card, after you done your part, I say because I'm black."
— Crystal Washington, 1★

LūM Granger

★ 4.8
7221 N Fir Rd, Granger, IN 46530
(574) 968-5166
"These people are some of the most friendly, caring professionals I’ve encountered. Thank you so much"
— Lisa Harkins, 5★

Medical Behavioral Hospital of Mishawaka

★ 2.2 (122 reviews)
1625 E Jefferson Blvd, Mishawaka, IN 46545
(574) 255-1400
"Im not very happy about my "made up" diagnosis. I would like it reversed.<br><br>7 days."
— Richard Hemenway, 1★

Goshen Center for Cancer Care

★ 3.8 (33 reviews)
200 High Park Ave, Goshen, IN 46526
(574) 364-2888
"Dr. Schilder is the best! He keeps my spirits up with his quirky little statements, like Chatty Kathy, he's just the absolute best Dr and I consider …"
— Kathy Hite, 5★

Notre Dame Clinical Law Center

★ 3.5
725 Howard St, South Bend, IN 46617
(574) 631-7795
"It’s just not all it’s cracked up to be . They may and may not help."
— Glen Smarr, 2★

Clinical trials in Elkhart: what's recruiting

The Elkhart area currently has 105 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Elkhart, the most active research areas are:

  • Cancer & Oncology14 studies
  • Liver & Kidney6 studies
  • Diabetes & Metabolism4 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Elkhart, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Elkhart

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Elkhart participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Elkhart?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Elkhart?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Elkhart?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Elkhart.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Elkhart typically complete one or two studies per year.

Paid clinical trials near Elkhart

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IN

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts